Melatonin provides neuroprotection by reducing oxidative stress and HSP70 expression during chronic cerebral hypoperfusion in ovariectomized rats

Journal of Pineal Research

Volumn 47, Issue 2, 2009, Pages 156-163

  Ozacmak, Veysel H ^a   Barut, Figen ^a   Ozacmak, Hale S ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Chronic cerebral hypoperfusion; Heat shock protein 70; Melatonin; Oxidative stress; Rat

Indexed keywords

GLUTATHIONE; HEAT SHOCK PROTEIN 70; MALONALDEHYDE; MELATONIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; LIPID PEROXIDATION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

ANIMALS; BRAIN ISCHEMIA; CHRONIC DISEASE; FEMALE; GLUTATHIONE; HIPPOCAMPUS; HISTOCYTOCHEMISTRY; HSP70 HEAT-SHOCK PROTEINS; MALONDIALDEHYDE; MELATONIN; NEUROPROTECTIVE AGENTS; OVARIECTOMY; OXIDATIVE STRESS; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; WEIGHT LOSS;

EID: 68249128780     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2009.00695.x     Document Type: Article

References (60)

1. Reiter J, Tan D-X, Manchester LC et al. Melatonin defeats neurally derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. J Physiol Pharmacol 2007 58 (Suppl. 6 5 22.
2. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007 42 : 386 393.
3. Manda K, Ueno M, Anzai K. Space radiation-induced inhibition of neurogenesis in the hippocampal dentate gyrus and memory impairment in mice: ameliorative potential of the melatonin metabolite, AFMK. J Pineal Res 2008 45 : 430 438.
4. Rennie K, De Butte M, Fréchette M, Pappas BA. Chronic and acute melatonin effects in gerbil global forebrain ischemia: long-term neural and behavioral outcome. J Pineal Res 2008 44 : 149 156.
5. Chen HY, Chen TY, Lee MY et al. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res 2006 41 : 175 182.
6. Lee MY, Kuan YH, Chen HY et al. Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats. J Pineal Res 2007 42 : 297 309.
7. Kilic E, Kilic U, Bacigaluppi M et al. Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J Pineal Res 2008 45 : 142 148.
8. Feng Z, Chuan Q, Chang Y et al. Early melatonin supplementation alleviates oxidative stress in a transgenic Mouse model of Alzheimer's disease. Free Radic Biol Med 2006 40 : 101 109.
9. Sharma R, Mcmillan CR, Tenn CC et al. Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of parkinson's disease. Brain Res 2006 1068 : 230 236.
10. Pei Z, Pang SF, Cheung RT. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. Stroke 2003 34 : 770 775. (Pubitemid 36307409)
11. Andrabi SA, Sayeed I, Siemen D et al. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 2004 18 : 869 871.
12. Reiter RJ, Sainz RM, Lopez-Burillo S et al. Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental models of stroke. Ann N Y Acad Sci 2003 993 : 35 47.
13. Reiter RJ, Carneiro RC, Oh CS. Melatonin in relation to cellular antioxidative defense mechanisms. Horm Metab Res 1997 29 : 363 372.
14. Antolin I, Rodriguez C, Sainz RM et al. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J 1996 10 : 882 890.
15. Subramanian P, Mirunalini S, Pandi-Perumal SR et al. Melatonin treatment improves the antioxidant status and decreases lipid content in brain and liver of rats. Eur J Pharmacol 2007 571 : 116 119.
16. Chang HM, Huang YL, Lan CT et al. Melatonin preserves superoxide dismutase activity in hypoglossal motoneurons of adult rats following peripheral nerve injury. J Pineal Res 2008 44 : 172 180.
17. Hung MW, Tipoe GL, Poon AM et al. Protective effect of melatonin against hippocampal injury of rats with intermittent hypoxia. J Pineal Res 2008 44 : 214 221.
18. Peng Y, Xu S, Chen G et al. l-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats. J Pharmacol Exp Ther 2007 321 : 902 910.
19. He Z, Huang L, Wu Y et al. DPH: Improving cognitive deficits beyond its alpha(1)-adrenoceptor antagonism in chronic cerebral hypoperfused rats. Eur J Pharmacol 2008 588 : 178 188.
20. Reiter RJ, Tan DX, Manchester LC et al. Melatonin reduces oxidative damage and promotes mitochondrial respiration: implications for aging. Ann NY Acad Sci 2002 959 : 238 250.
21. Delagrange P, Atkinson J, Boutin JA et al. Therapeutic perspectives for melatonin agonists and antagonists. J Neuroendocrinol 2003 15 : 442 448.
22. Wang LM, Han YF, Tang XC et al. Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats. Eur J Pharmacol 2000 398 : 65 72.
23. Kasparova S, Brezova V, Valko M et al. Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem Int 2005 46 : 601 611.
24. Guang HM, Du GH. Protections of pinocembrin on brain mitochondria contribute to cognitive improvement in chronic cerebral hypoperfused rats. Eur J Pharmacol 2006 542 : 77 83.
25. Kuang X, Du JR, Liu YX et al. Postischemic administration of Z-Ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats. Pharmacol Biochem Behav 2008 88 : 213 221.
26. Henderson VW. Menopause and disorders of the central nervous system. Minerva Ginecol 2005 57 : 579 592.
27. Harrod CG, Bendok BR, Hunt Batjer H. Interactions between melatonin and estrogen may regulate cerebrovascular function in women: clinical implications for the effective use of HRT during menopause and aging. Med Hypotheses 2005 64 : 725 735.
28. Atkinson J. Cerebrovascular structure and dementia: new drug targets. Trends Pharmacol Sci 2001 22 : 630 635.
29. El-Abhar HS, Shaalan M, Barakat M, El-Denshary ES. Effect of melatonin and nifedipine on some antioxidant enzymes and different energy fuels in the blood and brain of global ischemic rats. J Pineal Res 2002 33 : 87 94.
30. Casini A, Ferrali A, Pompella A et al. Lipid peroxidation and cellular damage in extrahepatic tissues of bromobenzene in toxicated mice. Am J Pathol 1986 123 : 520 531.
31. Aykac G, Uysal M, Yalan AS et al. The effects of chronic ethanol injection on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione transferase in rats. Toxicology 1985 36 : 71 76.
32. Heikkila RE, Cabbat F. A sensitive assay for superoxide dismutase based on the autoxidation of 6-hydroxydopamine. Anal Biochem 1976 75 : 356 362.
33. Lowry OH. Protein measurement with folin phenol reagent. J Biol Chem 1951 193 : 265 267.
34. Rodriguez C, Mayo JC, Sainz RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004 36 : 1 9.
35. Lee JH, Park SY, Shin YW et al. Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion. Brain Res 2006 1082 : 182 191.
36. Liang HW, Qiu SF, Shen J et al. Genistein attenuates oxidative stress and neuronal damage following transient global cerebral ischemia in rat hippocampus. Neurosci Lett 2008 438 : 116 120.
37. Imai H, Graham DI, Masayasu H et al. Antioxidant ebselen reduces oxidative damage in focal cerebral ischemia. Free Radic Biol Med 2003 34 : 56 63.
38. Reiter RJ, Paredes SD, Korkmaz A et al. Melatonin combats molecular terrorism at the mitochondrial level. Interdisc Toxicol 2008 1 : 137 149.
39. Tan DX, Manchester LC, Terron MP et al. Melatonin as a naturally occuring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance. J Pineal Res 2007 43 : 317 320.
40. Sinnha K, Degaonkar MN, Jagannathan NR, Gupta YK. Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats. Eur J Pharmacol 2001 428 : 185 192.
41. Carneiro RC, Reiter RJ. Melatonin protects against lipid peroxidation induced by delta-aminolevulinic acid in rat cerebellum, cortex and hippocampus. Neuroscience 1998 82 : 293 299.
42. Dringen R, Gutterer JM, Hirrlinger J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem 2000 267 : 4912 4916.
43. Anderson MF, Nilsson M, Eriksson PS, Sims NR. Glutathione monoethyl ester provides neuroprotection in a rat model of stroke. Neurosci Lett 2004 354 : 163 165.
44. Urata Y, Honma S, Goto S et al. Melatonin induces gamma-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radic Biol Med 1999 27 : 838 847.
45. Regrigny O, Dupuis F, Atkinson J et al. Cerebral arteriolar structure and function in pinealectomized rats. Am J Physiol Heart Circ Physiol 2001 281 : H1476 H1480.
46. Cho KO, La HO, Cho YJ et al. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. J Neurosci Res 2006 83 : 285 291.
47. Wakita H, Tomimoto H, Akiguchi I et al. Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat. Brain Res 2003 992 : 53 59.
48. Esposito E, Iacono A, Muià C et al. Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J Pineal Res 2008 44 : 78 87.
49. Cuzzocrea S, Zingarelli B, Constantino G, Caputi AP. Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J Pineal Res 1998 25 : 78 85.
50. Kilic E, Kilic U, Reiter RJ et al. Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt. J Pineal Res 2005 39 : 151 155.
51. Yousuf S, Atif F, Ahmad M et al. Selenium plays a modulatory role against cerebral ischemia-induced neuronal damage in rat hippocampus. Brain Res 2007 1147 : 218 225.
52. Kokubo Y, Liu J, Rajdev S et al. Differential cerebral protein synthesis and heat shock protein 70 expressions in the core and pneumbra of rat brain after transient focal ischemia. Neurosurgery 2003 53 : 186 191.
53. Tsuchiya D, Hong S, Matsumori Y et al. Overexpression of rat heat shock protein 70 is associated with reduction of early mitochondrial cytochrome c release and subsequent DNA fragmentation after permanent focal ischemia. J Cereb Blood Flow Metab 2003 23 : 718 727.
54. Yenari MA. Heat shock proteins and neuroprotection. Adv Exp Med Biol 2002 513 : 281 299.
55. Zheng Z, Kim JY, Ma H et al. Anti-inflammatory effects of the 70 kDa heat shock protein in experimental stroke. J Cereb Blood Flow Metab 2008 28 : 53 63.
56. Goldbaum O, Richter LC. Stress proteins in oligodendrocytes: differential effects of heat shock and oxidative stress. J Neurochem 2001 78 : 1233 1242.
57. Fehrenbach E, Northoff H. Free radicals exercise apoptosis and heat shock proteins. Immunol Rev 2001 7 : 66 89.
58. Guo S, Wharton W, Moseley P, Shi H. Heat shock protein 70 regulates cellular redox status by modulating glutathione-related enzyme activities. Cell Stress Chaperones 2007 12 : 245 254.
59. Meki AR, Esmail EEL-D, Hussein AA, Hassanein HM. Caspase-3 and heat shock protein-70 in rat liver treated with aflatoxin B1: effect of melatonin. Toxicon 2004 43 : 93 100.
60. Lin AM, Feng SF, Chao PL, Yang CH. Melatonin inhibits arsenite-induced peripheral neurotoxicity. J Pineal Res 2008 46 : 64 70.